Continuous glucose monitoring in India has gone from a niche specialty tool to a mainstream diabetes-management option in 2026. With FreeStyle Libre 2 widely available, Dexcom G7 imported through major pharmacies, and generic semaglutide changing how doctors treat diabetes — patients increasingly ask whether continuous glucose monitoring is worth the cost. As a diabetologist running a CGM-led practice at Nirvana Clinic in Greater Noida, here is the honest, evidence-based answer.

The short version: for the right patient, continuous glucose monitoring is a genuine game-changer. For others, it adds anxiety and cost without useful information. This guide covers what CGM actually is, the devices available in India, who benefits most, what it costs, and how to interpret CGM data clinically.

What is Continuous Glucose Monitoring? — The Simple Explanation

Continuous glucose monitoring (CGM) is a small wearable sensor that measures your glucose every 1–5 minutes, around the clock — without finger pricks. A traditional glucometer gives you a single reading at a single moment. A CGM gives you 288 or more readings every day, automatically.

The sensor is placed under the skin — usually on the back of the upper arm or on the abdomen. It measures glucose in the interstitial fluid (the fluid just under the skin) and transmits readings wirelessly to your phone or a small reader device. The result is a continuous graph of how your sugar moves after meals, during sleep, during exercise, and during stress. You see patterns that 2–4 daily finger pricks can never reveal.

How CGM differs from a traditional glucometer

CGM Devices Available in India in 2026

As of 2026, three continuous glucose monitoring options are practically accessible to Indian patients. The right device depends on your insulin regimen, budget, and how much real-time data you actually need.

3. Medtronic Guardian Connect — primarily used alongside Medtronic insulin pumps. Standalone use is uncommon in India. If you are not on a Medtronic pump, FreeStyle Libre or Dexcom is almost always the better choice.

Who Should Definitely Use Continuous Glucose Monitoring?

As a diabetologist, I recommend continuous glucose monitoring strongly for these patient groups:

• ✓
  Type 1 Diabetes patients — CGM is essentially standard of care. Blood sugar swings are frequent and unpredictable. Nighttime lows can be dangerous. CGM with alerts is genuinely life-changing for Type 1 patients and their families.
• ✓
  Type 2 patients on insulin — Especially those on basal-bolus regimens or those who have experienced hypoglycaemia. CGM helps with insulin dose titration and prevents dangerous lows.
• ✓
  Patients with hypoglycaemia unawareness — Some long-standing diabetics stop feeling the symptoms of low sugar. This is dangerous. CGM alerts catch lows before they become emergencies.
• ✓
  Patients with highly variable HbA1c — If your HbA1c keeps fluctuating despite treatment, CGM reveals what your medication and meal timing is actually doing to your sugar throughout the day.
• ✓
  Pregnant women with gestational, Type 1 or Type 2 diabetes — Tight glucose control during pregnancy is critical. CGM provides the data density needed for this.
• ✓
  Patients on GLP-1 therapy (Ozempic, Mounjaro, generic semaglutide) — As GLP-1 dose is titrated up, glucose patterns change rapidly. CGM during titration helps catch over-correction and supports safe medication tapering.

Who Will Benefit From CGM But May Not Need It Permanently?

These patients benefit significantly from continuous glucose monitoring — but often for a defined period rather than ongoing use:

• ✓
  Newly diagnosed Type 2 patients — A 2–4 week CGM trial at diagnosis is enormously educational. Patients see exactly which Indian foods spike their sugar — basmati vs brown rice, atta roti vs millet roti, dal vs rajma — and how exercise and stress affect glucose. This changes behaviour far more than advice alone.
• ✓
  Patients pursuing diabetes reversal — If you are on a structured diabetes reversal programme (low-carb, intermittent fasting, calorie restriction, or GLP-1-supported), CGM gives real-time feedback on whether your approach is working. Read more about diabetes reversal in India →
• ✓
  Prediabetes with strong family history — A 2-week CGM trial reveals postprandial spikes that fasting glucose or even HbA1c miss. Many patients I see at Nirvana Clinic have a "normal" fasting sugar but spike to 180+ after a meal of white rice — only continuous glucose monitoring shows this.
• ✓
  PCOD with insulin resistance — A short CGM trial helps women with PCOD identify which foods drive insulin resistance and fatigue. Often more useful than repeated HOMA-IR testing.

Who Does NOT Need Continuous Glucose Monitoring?

CGM is not for everyone, and I want to be honest about this — it is overprescribed by some clinics and underused by others.

• ✗
  Well-controlled Type 2 on oral medications only — If your HbA1c is stable at 6.5–7.5%, you are on metformin or similar (no insulin), and you have no hypoglycaemia — a glucometer 2–3 times a week is sufficient. Continuous glucose monitoring adds cost without meaningful new information.
• ✗
  Anxiety-prone patients without clinical need — Some patients become obsessed with every glucose fluctuation and develop significant health anxiety from CGM data. If you are prone to anxiety, CGM without proper clinical guidance can do more harm than good.
• ✗
  Patients who cannot afford sustained use — If ₹3,000/month is a financial strain, a well-timed glucometer is more sustainable and practically as effective for stable Type 2 patients on oral medications.
• ✗
  Patients without a clinician to interpret the data — CGM data without expert review is just numbers. The value comes from a clinician helping you understand what to change.

What Continuous Glucose Monitoring Data Tells Your Doctor

When a patient brings their CGM data to a consultation at Nirvana Clinic, here is what I can see that I cannot see from an HbA1c or spot glucometer reading:

• Time in Range (TIR) — what percentage of the day your sugar stays between 70–180 mg/dL. The international consensus is now that TIR is more meaningful than HbA1c alone. Goal: above 70%.
• Postprandial peaks — how high your sugar goes after each meal and which foods are the worst offenders for you specifically
• Nighttime patterns — whether you are going low between 2–4 AM (common with certain insulin regimens) or having a dawn phenomenon rise
• Exercise response — how your sugar responds to different types of activity (walking vs strength training vs HIIT)
• Glucose variability — how much your sugar swings, which is now recognised as an independent cardiovascular risk factor separate from average glucose

This data lets me make precise medication adjustments — changing the timing of insulin, adjusting metformin or GLP-1 doses, or modifying dietary recommendations — that would be impossible from 2–3 daily finger pricks.

Cost and Insurance Coverage for CGM in India

Currently, continuous glucose monitoring sensors are not covered by most health insurance policies in India, although this is beginning to change. Some corporate group policies and a few premium individual policies are starting to include CGM reimbursement, particularly for Type 1 diabetes. Worth checking with your specific insurer.

Realistic monthly cost in India (2026):

• FreeStyle Libre 2: ₹2,500–3,000 per sensor × 2 per month = ~₹5,000–6,000/month for continuous use. Most patients use intermittently, so true monthly cost is often ₹3,000.
• Dexcom G7: ₹4,000–5,500 per sensor × 3 per month = ~₹12,000–16,500/month for continuous use. Premium tier — usually only justified for Type 1 or insulin-pump users.
• Reader/app: No recurring cost. The sensor is the ongoing expense.

How to Get Continuous Glucose Monitoring Set Up in Greater Noida

FreeStyle Libre 2 sensors are stocked at most large pharmacies in Greater Noida and can be ordered online through 1mg, PharmEasy, Apollo Pharmacy, or Tata 1mg. Dexcom G7 has limited retail availability — usually ordered online or through specialty distributors.

At Nirvana Clinic's CGM service, we help you with the entire setup — sensor application, app configuration on Android or iOS, understanding your reports, and most importantly adjusting diet, exercise and medication based on the actual data. We see patients from across Delhi NCR, including Noida, Noida Extension, Gaur City, Pari Chowk, Jaypee Greens, and the wider Greater Noida region.

Dr. Manuj Sondhi

MRCP UK · MD Internal Medicine · Diabetologist & Physician · 17 Research Publications

Dr. Manuj Sondhi is Greater Noida's only MRCP UK-certified diabetologist, running a CGM-guided diabetes programme at Nirvana Clinic, Sun Twilight Mall. He has 15+ years of clinical experience, 17 peer-reviewed publications, and trained at Sir Ganga Ram Hospital (Delhi) and Tata Memorial Hospital (Mumbai). Patients travel from across Delhi NCR — Noida, Noida Extension, Gaur City, Pari Chowk and Greater Noida West — for continuous glucose monitoring setup and data review.

View Full Profile →

Related Reading on Diabetes & Glucose Monitoring